ADLI American Medical Technologies Inc (CE)

American Medical Technologies, Inc. (�AMT�) (OTCBB:ADLI) announced today the appointment of Judd D. Hoffman as Vice President of World Wide Sales and Operations, effective September 15, 2006. Mr. Hoffman brings to the Company a strong background in cosmetic dentistry sales, global operational management and international market strategy development. Mr. Hoffman was previously the Vice President of World Sales for Remedent, Inc. in El Segundo, California and Executive Director of International Operations for Discus Dental in Culver City, California. �AMT is entering into a new phase of aggressive growth in the global market, and we are establishing a strong management structure to drive this effort. With Judd�s experience and industry track record, we are pleased to have him join our AMT team and we look forward to his leadership during this important period of brand and product expansion,� stated Roger W. Dartt, President and Chief Executive Officer. AMT develops, manufactures and markets the high-technology HydrobrasionTM technique and recently acquired the exclusive worldwide distribution rights to the Spectrum Dental tooth whitening product line. This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform ACT of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. When used in this release, the words �anticipate,� �believe,� �estimate,� �expect� and similar expressions are intended to identify such forward-looking statements. AMT�s actual results, performance or achievements could differ materially from the results expressed in, or implied by these forward-looking statements. For more detailed information relating to the risks and uncertainties pertaining to these forward-looking statements, the reader is referred to the �risk-factors� section in AMT�s Form 10-KSB and other related documents filed with the Securities and Exchange Commission. American Medical Technologies, Inc. ("AMT") (OTCBB:ADLI) announced today the appointment of Judd D. Hoffman as Vice President of World Wide Sales and Operations, effective September 15, 2006. Mr. Hoffman brings to the Company a strong background in cosmetic dentistry sales, global operational management and international market strategy development. Mr. Hoffman was previously the Vice President of World Sales for Remedent, Inc. in El Segundo, California and Executive Director of International Operations for Discus Dental in Culver City, California. "AMT is entering into a new phase of aggressive growth in the global market, and we are establishing a strong management structure to drive this effort. With Judd's experience and industry track record, we are pleased to have him join our AMT team and we look forward to his leadership during this important period of brand and product expansion," stated Roger W. Dartt, President and Chief Executive Officer. AMT develops, manufactures and markets the high-technology Hydrobrasion(TM) technique and recently acquired the exclusive worldwide distribution rights to the Spectrum Dental tooth whitening product line. This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform ACT of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. When used in this release, the words "anticipate," "believe," "estimate," "expect" and similar expressions are intended to identify such forward-looking statements. AMT's actual results, performance or achievements could differ materially from the results expressed in, or implied by these forward-looking statements. For more detailed information relating to the risks and uncertainties pertaining to these forward-looking statements, the reader is referred to the "risk-factors" section in AMT's Form 10-KSB and other related documents filed with the Securities and Exchange Commission.